Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Jul;190(2):185-188.
doi: 10.1111/bjh.16896. Epub 2020 Jun 22.

Persisting SARS-CoV-2 viraemia after rituximab therapy: two cases with fatal outcome and a review of the literature

Affiliations
Case Reports

Persisting SARS-CoV-2 viraemia after rituximab therapy: two cases with fatal outcome and a review of the literature

Phil-Robin Tepasse et al. Br J Haematol. 2020 Jul.

Abstract

SARS-CoV-2 infection can cause severe pneumonia (COVID-19). There is evidence that patients with comorbidities are at higher risk of a severe disease course. The role of immunosuppression in the disease course is not clear. In the present report, we first describe two cases of persisting SARS-CoV-2 viraemia with fatal outcome in patients after rituximab therapy.

Keywords: COVID-19; SARS-CoV-2; pneumonia; rituximab; viraemia.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Chest X‐ray and thoracic CT imaging. Radiographic imaging showed bipulmonal, peripheral ground glass infiltration in both patients, a frequent finding in COVID‐19 pneumonia.
Fig 2
Fig 2
Development of pro‐inflammatory markers during disease course. C‐reactive protein (standard value <0·5 mg/l), IL‐6 (standard value <6 pg/ml) and ferritin (standard value 30–400 µg/l) increased over time. Vertical lines indicate the date of intubation. Detection of SARS‐CoV‐2 viraemia by real‐time PCR. Viral load increased over time in both patients until death. [Colour figure can be viewed at wileyonlinelibrary.com]

Comment in

Similar articles

Cited by

References

    1. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses . The species severe acute respiratory syndrome‐related coronavirus: classifying 2019‐nCoV and naming it SARS‐CoV‐2. Nat Microbiol. 2020;5:536–44. DOI: 10.1038/s41564-020-0695-z. - DOI - PMC - PubMed
    1. Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN. Cardiovascular disease, drug therapy, and mortality in Covid‐19. N Engl J Med. 2020. [Online ahead of print]. DOI: 10.1056/NEJMoa2007621. - DOI - PMC - PubMed
    1. Hui DS, Azhar EI, Kim YJ, Memish ZA, Oh MD, Zumla A. Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission. Lancet Infect Dis. 2018;18:e217–7. DOI: 10.1016/S1473-3099(18)30127-0. - DOI - PMC - PubMed
    1. Minotti C, Tirelli F, Barbieri E, Giaquinto C, Dona D. How is immunosuppressive status affecting children and adults in SARS‐CoV‐2 infection? A systematic review. J Infect. 2020. [Epub ahead of print]. DOI: 10.1016/j.jinf.2020.04.026. - DOI - PMC - PubMed
    1. Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, et al. Detection of 2019 novel coronavirus (2019‐nCoV) by real‐time RT‐PCR. Euro Surveill. 2020;25:2000045. DOI: 10.2807/1560-7917.ES.2020.25.3.2000045. - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources